Home  |  Contact

Cellosaurus HOVTAX2-paclitaxel resistant (CVCL_AV60)

[Text version]
Cell line name HOVTAX2-paclitaxel resistant
Accession CVCL_AV60
Resource Identification Initiative To cite this cell line use: HOVTAX2-paclitaxel resistant (RRID:CVCL_AV60)
Comments Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
Disease Ovarian serous surface papillary adenocarcinoma (NCIt: C6256)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_AV53 (HOVTAX2)
Sex of cell Female
Age at sampling Age unspecified
Category Cancer cell line
Publications

PubMed=22115851; DOI=10.1016/j.ygyno.2011.11.019
Vishnu P., Colon-Otero G., Kennedy G.T., Marlow L.A., Kennedy W.P., Wu K.J., Santoso J.T., Copland J.A. III
RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.
Gynecol. Oncol. 124:589-597(2012)

Cross-references
Encyclopedic resources Wikidata; Q54890192
Entry history
Entry creation02-May-2016
Last entry update29-Jun-2023
Version number7